IM Cannabis Q2 2026 revenue falls 40% as shipment delays and cash constraints curb imports, company says

• IM Cannabis posted Q2 2026 net revenue of CAD 7.59 million, down 40%, citing shipment delays, product mix shifts, pricing pressure, lower volumes.
• Gross profit fell to CAD 1.51 million from CAD 3.43 million, leaving gross margin at 20% versus 27% a year earlier.
• Germany revenue slipped to CAD 4.68 million from CAD 6.8 million, reflecting weaker demand and product availability tied to delayed shipments.
• Israel revenue dropped by CAD 2.98 million year over year, driven by reduced imports tied to cash-flow constraints, weighing on sales volumes.
• Net loss widened to CAD 4.39 million from CAD 194,000, pressured by lower gross profit and sharply higher financing expense.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IM Cannabis Corp. published the original content used to generate this news brief on August 13, 2026, and is solely responsible for the information contained therein.